Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

246 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Screening of hypercortisolism among patients with hypertension: an Italian nationwide survey.
Di Dalmazi G, Goi J, Burrello J, Tucci L, Cicero AFG, Mancusi C, Coletti Moia E, Iaccarino G, Borghi C, Muiesan ML, Ferri C, Mulatero P. Di Dalmazi G, et al. Among authors: mulatero p. J Endocrinol Invest. 2024 Dec;47(12):3029-3038. doi: 10.1007/s40618-024-02387-2. Epub 2024 Jun 24. J Endocrinol Invest. 2024. PMID: 38913251 Free PMC article.
Management of Renovascular Hypertension and Renal Denervation in Patients with Hypertension: An Italian Nationwide Survey.
Pappaccogli M, Ponsa L, Goi J, Burrello J, Di Dalmazi G, Cicero AFG, Mancusi C, Moia EC, Iaccarino G, Borghi C, Muiesan ML, Ferri C, Rabbia F, Mulatero P; Italian Society of Arterial Hypertension (SIIA). Pappaccogli M, et al. Among authors: mulatero p. High Blood Press Cardiovasc Prev. 2024 Sep;31(5):501-512. doi: 10.1007/s40292-024-00668-8. Epub 2024 Sep 18. High Blood Press Cardiovasc Prev. 2024. PMID: 39292380 Free PMC article.
Age- and sex-related variations in extracellular vesicle profiling for the assessment of cardiovascular risk: the EVaging index.
Burrello J, Goi J, Burrello A, Vacchi E, Rendon-Angel A, Lazzarini E, Bianco G, Limongelli V, Vassalli G, Cereda CW, Monticone S, Mulatero P, Bussolati B, Alimonti A, Camici GG, Melli G, Osto E, Pedrazzini G, Lucio B. Burrello J, et al. Among authors: mulatero p. NPJ Aging. 2024 Dec 19;10(1):63. doi: 10.1038/s41514-024-00189-7. NPJ Aging. 2024. PMID: 39702460 Free PMC article.
Outcomes after adrenalectomy for unilateral primary aldosteronism: an international consensus on outcome measures and analysis of remission rates in an international cohort.
Williams TA, Lenders JWM, Mulatero P, Burrello J, Rottenkolber M, Adolf C, Satoh F, Amar L, Quinkler M, Deinum J, Beuschlein F, Kitamoto KK, Pham U, Morimoto R, Umakoshi H, Prejbisz A, Kocjan T, Naruse M, Stowasser M, Nishikawa T, Young WF Jr, Gomez-Sanchez CE, Funder JW, Reincke M; Primary Aldosteronism Surgery Outcome (PASO) investigators. Williams TA, et al. Among authors: mulatero p. Lancet Diabetes Endocrinol. 2017 Sep;5(9):689-699. doi: 10.1016/S2213-8587(17)30135-3. Epub 2017 May 30. Lancet Diabetes Endocrinol. 2017. PMID: 28576687 Free PMC article.
Proteomic analysis of urinary extracellular vesicles highlights specific signatures for patients with primary aldosteronism.
Bertolone L, Castagna A, Manfredi M, De Santis D, Ambrosani F, Antinori E, Mulatero P, Danese E, Marengo E, Barberis E, Veneri M, Martinelli N, Friso S, Pizzolo F, Olivieri O. Bertolone L, et al. Among authors: mulatero p. Front Endocrinol (Lausanne). 2023 May 8;14:1096441. doi: 10.3389/fendo.2023.1096441. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 37223008 Free PMC article.
Safety and efficacy of once-daily dexfadrostat phosphate in patients with primary aldosteronism: a randomised, parallel group, multicentre, phase 2 trial.
Mulatero P, Wuerzner G, Groessl M, Sconfienza E, Damianaki A, Forestiero V, Vogt B, Brunner H, Gerlock T, Steele R, Schumacher C. Mulatero P, et al. EClinicalMedicine. 2024 Apr 6;71:102576. doi: 10.1016/j.eclinm.2024.102576. eCollection 2024 May. EClinicalMedicine. 2024. PMID: 38618204 Free PMC article.
Screening of primary aldosteronism and pheochromocytoma among patients with hypertension: an Italian nationwide survey.
Monticone S, Goi J, Burrello J, Di Dalmazi G, Cicero AFG, Mancusi C, Moia EC, Iaccarino G, Veglio F, Borghi C, Muiesan ML, Ferri C, Mulatero P; Italian Society of Arterial Hypertension (SIIA). Monticone S, et al. Among authors: mulatero p. J Endocrinol Invest. 2025 Jan 18. doi: 10.1007/s40618-025-02532-5. Online ahead of print. J Endocrinol Invest. 2025. PMID: 39826012
Outcomes after medical treatment for primary aldosteronism: an international consensus and analysis of treatment response in an international cohort.
Yang J, Burrello J, Goi J, Reincke M, Adolf C, Asbach E, Brűdgam D, Li Q, Song Y, Hu J, Yang S, Satoh F, Ono Y, Libianto R, Stowasser M, Li N, Zhu Q, Hong N, Nayak D, Puar TH, Wu VC, Vaidya A, Araujo-Castro M, Kocjan T, O'Toole SM, Hundemer GL, Ragnarsson O, Lacroix A, Larose S, Nakai K, Nishikawa T, Ladygina D, Turcu AF, Sholinyan J, Fardella CE, Uslar T, Quinkler M, Mulatero P, Pintus G, Rossi GP, Hahner S, Amar L, Drake WM, Varsani C, Brown MJ, Wu X, Deinum J, Freel EM, Kline G, Naruse M, Prejbisz A, Young WF Jr, Williams TA, Fuller PJ. Yang J, et al. Among authors: mulatero p. Lancet Diabetes Endocrinol. 2025 Jan 14:S2213-8587(24)00308-5. doi: 10.1016/S2213-8587(24)00308-5. Online ahead of print. Lancet Diabetes Endocrinol. 2025. PMID: 39824204
246 results